Market Open
Home Calendar Movers Compare
S&P 500 755.72 -1.77% Nasdaq 690.49 -3.47% Dow 30 517.13 -1.07% Apple 348.91 +1.48% Nvidia 204.64 -4.22% Tesla 399.81 -0.87%
Market Open | 920 companies reporting this week
Home / Calendar / KYMR

KYMR

Kymera Therapeutics Inc
$126.63
90-day price trend
+3.29% (+$4.03)
Volume 1.59M
52W High $130.05
52W Low $55.66
Market Cap $10.08B
← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported
Oct 29, 2026 Missed
Actual: -$1.32 vs. Consensus: -$1.26

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2026 Oct 29, 2026
1-Day: +3.29%
Q2 2026 Aug 5, 2026
1-Day: +0.88%
5-Day: +2.94%
Q1 2026 Apr 30, 2026
1-Day: -0.44%
5-Day: +2.02%
Q4 2025 Feb 26, 2026
1-Day: -3.87%
5-Day: -9.13%

Revenue & Financial Performance

Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $2.9M -61.3% 2,763.6% -3,422.9% -$87.0M
Q3'25 $2.8M -26.1% -2,580.7% -3,347.4% -$82.2M
Q2'25 $11.5M -55.3% 81.8% -736.8% -$76.6M
Q1'25 $22.1M +114.8% 100.0% -336.8% -$65.6M
Q4'24 $7.4M -84.6% 100.0% -1,092.2% -$70.8M
Q3'24 $3.7M -20.9% 100.0% -1,927.9% -$62.5M
Q2'24 $25.7M +55.3% 100.0% -198.5% -$42.1M
Q1'24 $10.3M +8.7% 100.0% -562.2% -$48.6M

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q3 2026 Oct 29, 2026 -$1.26 -$1.26 -$1.32 -4.76% Missed
Q2 2026 Aug 5, 2026 -$0.64 -$0.64 -$0.62 +3.13% Beat
Q1 2026 Apr 30, 2026 -$0.86 -$0.86 -$0.71 +17.44% Beat
Q4 2025 Feb 26, 2026 -$0.77 -$0.79 -$0.97 -25.97% Missed
Q4 2025 Feb 19, 2026 -$0.79 -$0.79 $0.00 +100.00% Beat
Q3 2025 Nov 4, 2025 -$0.78 -$0.87 -$0.94 -20.51% Missed
Q3 2025 Oct 29, 2025 -$0.86 -$0.86 -$0.94 -9.14% Missed
Q2 2025 Aug 11, 2025 -$0.80 -$0.83 -$0.95 -18.75% Missed
Q1 2025 May 9, 2025 -$0.91 -$0.73 -$0.82 +9.89% Missed
Q1 2025 Apr 30, 2025 -$0.73 -$0.73 -$0.82 -12.33% Missed
Q4 2024 Feb 27, 2025 -$0.79 -$0.79 -$0.89 -12.92% Missed
Q4 2024 Feb 20, 2025 -$0.79 -$0.79 -$0.89 -12.92% Missed

Company Information

Symbol
KYMR
Company
Kymera Therapeutics Inc
Market Cap
$10.08B